Agonist vs antagonist

Definition

Agonists and antagonists are two classes of compounds defined by their interaction with cellular receptors. An agonist is a molecule that binds to a receptor and activates it, triggering the normal biological response associated with that receptor. A partial agonist binds and activates the receptor but produces a submaximal response compared to a full agonist. An antagonist binds to a receptor without activating it, blocking agonists from binding and thereby preventing receptor activation and the associated biological response. Understanding whether a compound is an agonist, partial agonist, or antagonist is crucial for predicting its biological effects and safety profile. For example, GLP-1 receptor agonists activate GLP-1 receptors to enhance insulin secretion and promote satiety, while GLP-1 receptor antagonists would block these effects. Selectivity (the degree to which a compound preferentially targets one receptor over others) is equally important; a non-selective agonist that activates multiple unintended receptors can produce off-target effects and toxicity.

The affinity of a compound for a receptor (how tightly it binds) and its efficacy (how strongly it activates the receptor once bound) together determine whether the compound acts as an agonist, partial agonist, or antagonist. High-affinity, high-efficacy compounds are full agonists; high-affinity, low-efficacy compounds are partial agonists or antagonists depending on context; low-affinity compounds may not produce measurable effects at physiological concentrations. In research, compounds are characterized by measuring their binding affinity to receptors (in vitro binding assays) and their biological potency (in vivo efficacy studies).

Therapeutic peptides are often designed to act as selective agonists for specific receptors. For example, semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GLP-1 and GIP receptor agonist. The advantage of agonists is that they enhance the natural pathway; the advantage of antagonists is that they block unwanted pathways. Research into both agonists and antagonists helps reveal the physiological role of each receptor and its potential therapeutic targeting.